Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490620 · ClinicalTrials.gov registry record · Phase 2
Study of Combivir for Patients With Primary Biliary Cirrhosis
A Phase 2 study, sponsored by University of Alberta.
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT00490620: Completed Phase 2 study, sponsored by University of Alberta.
NCT00490620 is a Phase 2 study that has completed, run by University of Alberta. The registered enrollment target is 59 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490620, a Phase 2 study, has completed, sponsored by University of Alberta.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
This is a proof of principal study to determine whether combination anti-viral therapy with Combivir impacts on hepatic biochemistry in patients with primary biliary cirrhosis
Interventions
- DRUG Placebo
- DRUG Combination antiviral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
What the finished NCT00490620 record still lists
NCT00490620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00490620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00490620 about?
NCT00490620 is a clinical study titled "Study of Combivir for Patients With Primary Biliary Cirrhosis". This is a proof of principal study to determine whether combination anti-viral therapy with Combivir impacts on hepatic biochemistry in patients with primary biliary cirrhosis
What is the current status of trial NCT00490620?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2004-01. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00490620?
The interventions under investigation include: Placebo (DRUG), Combination antiviral therapy (DRUG).
Who is sponsoring clinical trial NCT00490620?
This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00490620's enrollment target sits among peer trials
59 1133rd of 2000 higher than 866 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia